Loading organizations...
Loading organizations...
Innovative products for patients with rare and life-threatening diseases.
Orbus Therapeutics has raised $103.5M across 2 funding rounds.
Orbus Therapeutics has raised $103.5M in total across 2 funding rounds.
Orbus Therapeutics has raised $103.5M in total across 2 funding rounds.
Orbus Therapeutics's investors include Adams Street Partners, H.I.G. BioHealth Partners, Longitude Capital, Kurt von Emster, Patrick Enright, Ernest Mario.
Orbus Therapeutics has raised $103.5M across 2 funding rounds. Most recently, it raised $71.0M Series A Extension in October 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 22, 2020 | $71.0M Series A Extension | Adams Street Partners, H.I.G. BioHealth Partners, Longitude Capital | Kurt von Emster |
| Aug 20, 2015 | $32.5M Series A | Adams Street Partners, H.I.G. BioHealth Partners, Patrick Enright | Ernest Mario |